nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—SLC22A8—Furosemide—dilated cardiomyopathy	0.352	0.589	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Furosemide—dilated cardiomyopathy	0.245	0.411	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0157	0.103	CbGpPWpGaD
Adefovir Dipivoxil—AK2—myocardium—dilated cardiomyopathy	0.0145	0.146	CbGeAlD
Adefovir Dipivoxil—AK4—cardiac ventricle—dilated cardiomyopathy	0.0114	0.115	CbGeAlD
Adefovir Dipivoxil—AK4—myocardium—dilated cardiomyopathy	0.0107	0.108	CbGeAlD
Adefovir Dipivoxil—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0106	0.07	CbGpPWpGaD
Adefovir Dipivoxil—AK2—heart—dilated cardiomyopathy	0.0101	0.102	CbGeAlD
Adefovir Dipivoxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00957	0.0631	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—DSP—dilated cardiomyopathy	0.00801	0.0528	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00799	0.0527	CbGpPWpGaD
Adefovir Dipivoxil—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00787	0.0518	CcSEcCtD
Adefovir Dipivoxil—NME1—heart—dilated cardiomyopathy	0.00778	0.0784	CbGeAlD
Adefovir Dipivoxil—AK4—heart—dilated cardiomyopathy	0.0075	0.0755	CbGeAlD
Adefovir Dipivoxil—NME2—heart—dilated cardiomyopathy	0.00733	0.0738	CbGeAlD
Adefovir Dipivoxil—NME1—Arf6 downstream pathway—RAC1—dilated cardiomyopathy	0.00668	0.0441	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—cardiac ventricle—dilated cardiomyopathy	0.00649	0.0653	CbGeAlD
Adefovir Dipivoxil—AK4—cardiac atrium—dilated cardiomyopathy	0.00642	0.0646	CbGeAlD
Adefovir Dipivoxil—ABCC5—myocardium—dilated cardiomyopathy	0.0061	0.0614	CbGeAlD
Adefovir Dipivoxil—ABCC5—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00545	0.0359	CbGpPWpGaD
Adefovir Dipivoxil—Glycosuria—Furosemide—dilated cardiomyopathy	0.00538	0.0354	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00531	0.035	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Spironolactone—dilated cardiomyopathy	0.0044	0.029	CcSEcCtD
Adefovir Dipivoxil—ABCC5—heart—dilated cardiomyopathy	0.00426	0.0429	CbGeAlD
Adefovir Dipivoxil—ABCC4—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00378	0.0249	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00371	0.0244	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—cardiac atrium—dilated cardiomyopathy	0.00364	0.0367	CbGeAlD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.00364	0.024	CbGpPWpGaD
Adefovir Dipivoxil—Cough increased—Lisinopril—dilated cardiomyopathy	0.00357	0.0235	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—ADRB2—dilated cardiomyopathy	0.00345	0.0228	CbGpPWpGaD
Adefovir Dipivoxil—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00343	0.0226	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.00334	0.022	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—RAC1—dilated cardiomyopathy	0.00332	0.0219	CbGpPWpGaD
Adefovir Dipivoxil—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00321	0.0211	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00296	0.0195	CcSEcCtD
Adefovir Dipivoxil—ABCC4—heart—dilated cardiomyopathy	0.00295	0.0297	CbGeAlD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00286	0.0188	CbGpPWpGaD
Adefovir Dipivoxil—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0028	0.0184	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00271	0.0179	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00268	0.0176	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00264	0.0174	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—RAC1—dilated cardiomyopathy	0.00264	0.0174	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00257	0.0169	CbGpPWpGaD
Adefovir Dipivoxil—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00249	0.0164	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00247	0.0162	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Furosemide—dilated cardiomyopathy	0.0024	0.0158	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0023	0.0152	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00226	0.0149	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00222	0.0146	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—TTN—dilated cardiomyopathy	0.0022	0.0145	CbGpPWpGaD
Adefovir Dipivoxil—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00216	0.0142	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00214	0.0141	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00213	0.014	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.0021	0.0138	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Spironolactone—dilated cardiomyopathy	0.00202	0.0133	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00201	0.0132	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00195	0.0129	CcSEcCtD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00195	0.0128	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00192	0.0126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00191	0.0126	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Furosemide—dilated cardiomyopathy	0.0019	0.0125	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Furosemide—dilated cardiomyopathy	0.00188	0.0123	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00186	0.0122	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00182	0.012	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Spironolactone—dilated cardiomyopathy	0.00182	0.012	CcSEcCtD
Adefovir Dipivoxil—Rash—Spironolactone—dilated cardiomyopathy	0.0018	0.0119	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0018	0.0118	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Lisinopril—dilated cardiomyopathy	0.0018	0.0118	CcSEcCtD
Adefovir Dipivoxil—Headache—Spironolactone—dilated cardiomyopathy	0.00179	0.0118	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Lisinopril—dilated cardiomyopathy	0.00178	0.0117	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Furosemide—dilated cardiomyopathy	0.00176	0.0116	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Lisinopril—dilated cardiomyopathy	0.00174	0.0115	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00173	0.0114	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00172	0.0113	CcSEcCtD
Adefovir Dipivoxil—Nausea—Spironolactone—dilated cardiomyopathy	0.0017	0.0112	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00164	0.0108	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00163	0.0107	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VCL—dilated cardiomyopathy	0.00162	0.0107	CbGpPWpGaD
Adefovir Dipivoxil—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00162	0.0107	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00161	0.0106	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00161	0.0106	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.0016	0.0105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00155	0.0102	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00152	0.01	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00152	0.01	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Furosemide—dilated cardiomyopathy	0.00151	0.00993	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Furosemide—dilated cardiomyopathy	0.00148	0.00975	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00146	0.00962	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00143	0.0094	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Lisinopril—dilated cardiomyopathy	0.00141	0.00926	CcSEcCtD
Adefovir Dipivoxil—Back pain—Lisinopril—dilated cardiomyopathy	0.00138	0.00909	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—TAZ—dilated cardiomyopathy	0.00137	0.00904	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00135	0.00889	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00883	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Lisinopril—dilated cardiomyopathy	0.00132	0.00869	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00127	0.00836	CcSEcCtD
Adefovir Dipivoxil—Cough—Lisinopril—dilated cardiomyopathy	0.00125	0.0082	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—SDHA—dilated cardiomyopathy	0.00124	0.00818	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00123	0.00808	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00123	0.00808	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Lisinopril—dilated cardiomyopathy	0.00122	0.008	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Lisinopril—dilated cardiomyopathy	0.00122	0.008	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00121	0.00795	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—dilated cardiomyopathy	0.0012	0.0079	CbGpPWpGaD
Adefovir Dipivoxil—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00114	0.00751	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00113	0.00745	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Furosemide—dilated cardiomyopathy	0.00112	0.00734	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Lisinopril—dilated cardiomyopathy	0.00111	0.00731	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Furosemide—dilated cardiomyopathy	0.0011	0.00724	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.00108	0.00712	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00106	0.007	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00106	0.00699	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00103	0.00675	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00101	0.00667	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00101	0.00666	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00101	0.00662	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Furosemide—dilated cardiomyopathy	0.000988	0.0065	CcSEcCtD
Adefovir Dipivoxil—Rash—Furosemide—dilated cardiomyopathy	0.00098	0.00645	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Furosemide—dilated cardiomyopathy	0.000979	0.00644	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000978	0.00645	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Furosemide—dilated cardiomyopathy	0.000974	0.00641	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000966	0.00637	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000954	0.00627	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—TAZ—dilated cardiomyopathy	0.00095	0.00627	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000924	0.00609	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Furosemide—dilated cardiomyopathy	0.000923	0.00607	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000922	0.00607	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000922	0.00607	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000891	0.00587	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000873	0.00576	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000871	0.00574	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—SDHA—dilated cardiomyopathy	0.000859	0.00567	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000848	0.00559	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Lisinopril—dilated cardiomyopathy	0.000837	0.00551	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Lisinopril—dilated cardiomyopathy	0.000825	0.00543	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000798	0.00525	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000766	0.00505	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Lisinopril—dilated cardiomyopathy	0.000741	0.00488	CcSEcCtD
Adefovir Dipivoxil—Rash—Lisinopril—dilated cardiomyopathy	0.000735	0.00484	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000735	0.00483	CcSEcCtD
Adefovir Dipivoxil—Headache—Lisinopril—dilated cardiomyopathy	0.000731	0.00481	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000727	0.00479	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000721	0.00475	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TAZ—dilated cardiomyopathy	0.00072	0.00475	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—CD36—dilated cardiomyopathy	0.000696	0.00459	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Lisinopril—dilated cardiomyopathy	0.000693	0.00456	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000663	0.00437	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SDHA—dilated cardiomyopathy	0.000651	0.00429	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000629	0.00415	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000612	0.00404	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000612	0.00404	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000579	0.00382	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000569	0.00375	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000505	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TTN—dilated cardiomyopathy	0.000504	0.00332	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000491	0.00324	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000491	0.00324	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000456	0.00301	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000455	0.003	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000443	0.00292	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000443	0.00292	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	0.000437	0.00288	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000436	0.00288	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000424	0.0028	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000424	0.0028	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000414	0.00273	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000411	0.00271	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000397	0.00262	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000394	0.0026	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TAZ—dilated cardiomyopathy	0.000389	0.00256	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00038	0.0025	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000378	0.00249	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	0.000371	0.00245	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000369	0.00244	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000369	0.00244	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SDHA—dilated cardiomyopathy	0.000352	0.00232	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000343	0.00226	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GPX1—dilated cardiomyopathy	0.000337	0.00222	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000332	0.00219	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CD36—dilated cardiomyopathy	0.000328	0.00216	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TAZ—dilated cardiomyopathy	0.000312	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000309	0.00204	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AGT—dilated cardiomyopathy	0.000295	0.00195	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000291	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SDHA—dilated cardiomyopathy	0.000282	0.00186	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GPX1—dilated cardiomyopathy	0.000233	0.00154	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CD36—dilated cardiomyopathy	0.000227	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NPPA—dilated cardiomyopathy	0.000215	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PSEN2—dilated cardiomyopathy	0.000208	0.00137	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AGT—dilated cardiomyopathy	0.000205	0.00135	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000193	0.00127	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	0.000187	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GPX1—dilated cardiomyopathy	0.000177	0.00117	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CD36—dilated cardiomyopathy	0.000172	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	0.000159	0.00105	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AGT—dilated cardiomyopathy	0.000155	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	0.00015	0.000989	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000124	0.000819	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RAC1—dilated cardiomyopathy	0.000105	0.00069	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.96e-05	0.000657	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	9.94e-05	0.000655	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPX1—dilated cardiomyopathy	9.55e-05	0.00063	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CD36—dilated cardiomyopathy	9.31e-05	0.000614	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.98e-05	0.000592	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.61e-05	0.000567	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AGT—dilated cardiomyopathy	8.38e-05	0.000552	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	7.66e-05	0.000505	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.49e-05	0.000494	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	7.46e-05	0.000492	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RAF1—dilated cardiomyopathy	6.94e-05	0.000458	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	6.72e-05	0.000443	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—dilated cardiomyopathy	4.76e-05	0.000314	CbGpPWpGaD
